169 related articles for article (PubMed ID: 25311653)
1. Level of vitreous alpha-B crystallin in eyes with rhegmatogenous retinal detachment.
Baba T; Oshitari T; Yamamoto S
Graefes Arch Clin Exp Ophthalmol; 2015 Aug; 253(8):1251-4. PubMed ID: 25311653
[TBL] [Abstract][Full Text] [Related]
2. Elevated vitreous αB-crystallin in patients with rhegmatogenous retinal detachment and association with proliferative vitreoretinopathy and retinal detachment area.
Yun J; Min JK
Int Ophthalmol; 2020 Oct; 40(10):2461-2467. PubMed ID: 32440819
[TBL] [Abstract][Full Text] [Related]
3. Increased levels of alphaB-crystallin in vitreous fluid of patients with proliferative diabetic retinopathy and correlation with vascular endothelial growth factor.
Chen W; Lu Q; Lu L; Guan H
Clin Exp Ophthalmol; 2017 May; 45(4):379-384. PubMed ID: 27928876
[TBL] [Abstract][Full Text] [Related]
4. Hepatocyte growth factor levels in the vitreous of patients with proliferative vitreoretinopathy.
Mitamura Y; Takeuchi S; Matsuda A; Tagawa Y; Mizue Y; Nishihira J
Am J Ophthalmol; 2000 May; 129(5):678-80. PubMed ID: 10844070
[TBL] [Abstract][Full Text] [Related]
5. Decreased hyaluronan concentration during primary rhegmatogenous retinal detachment.
Kaprinis K; Symeonidis C; Papakonstantinou E; Tsinopoulos I; Dimitrakos SA
Eur J Ophthalmol; 2016 Nov; 26(6):633-638. PubMed ID: 27198637
[TBL] [Abstract][Full Text] [Related]
6. Pigment epithelium-derived factor in the vitreous is low in diabetic retinopathy and high in rhegmatogenous retinal detachment.
Ogata N; Tombran-Tink J; Nishikawa M; Nishimura T; Mitsuma Y; Sakamoto T; Matsumura M
Am J Ophthalmol; 2001 Sep; 132(3):378-82. PubMed ID: 11530051
[TBL] [Abstract][Full Text] [Related]
7. The Expression of GDF-15 in the Human Vitreous in the Presence of Retinal Pathologies with an Inflammatory Component.
Ilhan HD; Bilgin AB; Toylu A; Dogan ME; Apaydin KC
Ocul Immunol Inflamm; 2016; 24(2):178-83. PubMed ID: 26177355
[TBL] [Abstract][Full Text] [Related]
8. Macrophage migration inhibitory factor levels in the vitreous of patients with proliferative vitreoretinopathy.
Mitamura Y; Takeuchi S; Matsuda A; Tagawa Y; Mizue Y; Nishihira J
Am J Ophthalmol; 1999 Dec; 128(6):763-5. PubMed ID: 10612518
[TBL] [Abstract][Full Text] [Related]
9. Elevated erythropoietin in vitreous of patients with rhegmatogenous retinal detachment and proliferative vitreoretinopathy.
Wang ZY; Shen LJ; Zhao KK; Song ZM; Qu J
Ophthalmic Res; 2009; 42(3):138-40. PubMed ID: 19602911
[TBL] [Abstract][Full Text] [Related]
10. Tenascin-C levels in the vitreous of patients with proliferative vitreoretinopathy.
Mitamura Y; Takeuchi S; Ohtsuka K; Matsuda A; Yamamoto T; Yamamoto S; Hiraiwa N; Kusakabe M
Ophthalmologica; 2003; 217(6):422-5. PubMed ID: 14573976
[TBL] [Abstract][Full Text] [Related]
11. Characterization of the biological antioxidant potential in the vitreous fluid from patients with rhegmatogenous retinal detachment.
Maeno A; Suzuki Y; Adachi K; Takahashi S; Yokoi Y; Nakazawa M
Acta Ophthalmol; 2016 Sep; 94(6):e515-6. PubMed ID: 27008980
[No Abstract] [Full Text] [Related]
12. Vitreous levels of oxidative stress biomarkers and the radical-scavenger α1-microglobulin/A1M in human rhegmatogenous retinal detachment.
Cederlund M; Ghosh F; Arnér K; Andréasson S; Akerström B
Graefes Arch Clin Exp Ophthalmol; 2013 Mar; 251(3):725-32. PubMed ID: 22829194
[TBL] [Abstract][Full Text] [Related]
13. Monocyte chemotactic protein-1 levels in the vitreous of patients with proliferative vitreoretinopathy.
Mitamura Y; Takeuchi S; Yamamoto S; Yamamoto T; Tsukahara I; Matsuda A; Tagawa Y; Mizue Y; Nishihira J
Jpn J Ophthalmol; 2002; 46(2):218-21. PubMed ID: 12062231
[TBL] [Abstract][Full Text] [Related]
14. Correlation between miR-148 Expression in Vitreous and Severity of Rhegmatogenous Retinal Detachment.
Tsunekawa T; Kaneko H; Takayama K; Hwang SJ; Oishi A; Nagasaka Y; Ye F; Iwase T; Nonobe N; Ueno S; Ito Y; Yasuda S; Matsuura T; Shimizu H; Suzumura A; Kataoka K; Terasaki H
Biomed Res Int; 2017; 2017():3427319. PubMed ID: 28261609
[No Abstract] [Full Text] [Related]
15. Comprehensive exploration of hub genes involved in oxidative stress in rhegmatogenous retinal detachment based on bioinformatics analysis.
Xu Q; Luo L; Xiang X; Feng Y; Cao Y; Zeng J; Lv H
Exp Eye Res; 2024 Mar; 240():109810. PubMed ID: 38296106
[TBL] [Abstract][Full Text] [Related]
16. Increased glutamate levels in the vitreous of patients with retinal detachment.
Diederen RM; La Heij EC; Deutz NE; Kijlstra A; Kessels AG; van Eijk HM; Liem AT; Dieudonné S; Hendrikse F
Exp Eye Res; 2006 Jul; 83(1):45-50. PubMed ID: 16530753
[TBL] [Abstract][Full Text] [Related]
17. Long-Term Changes in Intraocular Pressure after Vitrectomy for Rhegmatogenous Retinal Detachment, Epi-Retinal Membrane, or Macular Hole.
Yamamoto K; Iwase T; Terasaki H
PLoS One; 2016; 11(11):e0167303. PubMed ID: 27898707
[TBL] [Abstract][Full Text] [Related]
18. Vitreous intercellular adhesion molecule 1 in uveitis complicated by retinal detachment.
Webster L; Stanbury RM; Chignell AH; Limb GA
Br J Ophthalmol; 1998 Apr; 82(4):438-43. PubMed ID: 9640197
[TBL] [Abstract][Full Text] [Related]
19. Vitreous levels of apolipoprotein A1 and retinol binding protein 4 in human rhegmatogenous retinal detachment associated with choroidal detachment.
Ding N; Luo S; Yu J; Zhou Y; Wu Z
Mol Vis; 2018; 24():252-260. PubMed ID: 29618920
[TBL] [Abstract][Full Text] [Related]
20. Inverse levels of pigment epithelium-derived factor and vascular endothelial growth factor in the vitreous of eyes with rhegmatogenous retinal detachment and proliferative vitreoretinopathy.
Ogata N; Nishikawa M; Nishimura T; Mitsuma Y; Matsumura M
Am J Ophthalmol; 2002 Jun; 133(6):851-2. PubMed ID: 12036691
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
